AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 35313268 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.2% ropivacaine
Number of subjects: 118
Study 35313268 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.5 ml ropivacaine
Number of subjects: 118
Study 32955138 — intervention group
Group type: EXPERIMENTAL
Intervention: Abemaciclib
Number of subjects: 0
Study 32852361 — intervention group
Group type: EXPERIMENTAL
Intervention: Continue CTX prophylaxis
Number of subjects: 72
Study 32852361 — intervention group
Group type: COMPARATOR
Intervention: Stop CTX prophylaxis
Number of subjects: 72
Study 33443859 — intervention group
Group type: EXPERIMENTAL
Intervention: Lavender aromatherapy
Number of subjects: 144
Study 33443859 — intervention group
Group type: COMPARATOR
Intervention: Control (tablets devoid of any scent)
Number of subjects: 144
Study 35989130 — intervention group
Group type: EXPERIMENTAL
Intervention: Error-focused video feedback
Number of subjects: 37
Study 35989130 — intervention group
Group type: COMPARATOR
Intervention: Correct-focused video feedback
Number of subjects: 37
Study 34337074 — intervention group
Group type: EXPERIMENTAL
Intervention: Antibiotic-loaded bone cement repair
Number of subjects: 36
Study 34337074 — intervention group
Group type: COMPARATOR
Intervention: Conventional vacuum sealing draining treatment
Number of subjects: 36
Study 33189747 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypothermia
Number of subjects: 168
Study 33189747 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 168
Study 33189747 — intervention group
Group type: EXPERIMENTAL
Intervention: MRI injury score
Number of subjects: 168
Study 33189747 — intervention group
Group type: EXPERIMENTAL
Intervention: MRI patterns
Number of subjects: 168
Study 32795506 — intervention group
Group type: EXPERIMENTAL
Intervention: PICTURE (Predicting Intensive Care Transfers and other UnfoReseen Events)
Number of subjects: 133089
Study 32795506 — intervention group
Group type: COMPARATOR
Intervention: Regularized logistic regression
Number of subjects: 133089
Study 35168586 — intervention group
Group type: EXPERIMENTAL
Intervention: Education program with peer support on social media (Facebook Page of Antibiotic Use), 2 weekly sessions of 90 minutes each.
Number of subjects: 48
Study 35168586 — intervention group
Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned).
Number of subjects: 48
Study 35168586 — intervention group
Group type: EXPERIMENTAL
Intervention: Education program with peer support on social media (Facebook Page of Antibiotic Use).
Number of subjects: 48
Study 34106941 — intervention group
Group type: EXPERIMENTAL
Intervention: WW52 (52-week behavioural weight management intervention)
Number of subjects: 594
Study 34106941 — intervention group
Group type: COMPARATOR
Intervention: WW12 (12-week behavioural weight management intervention)
Number of subjects: 594
Study 34106941 — intervention group
Group type: COMPARATOR
Intervention: BI (brief self‐help intervention)
Number of subjects: 594
Study 33595905 — intervention group
Group type: EXPERIMENTAL
Intervention: Canagliflozin
Number of subjects: 10142
Study 33595905 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10142
Study 32916181 — intervention group
Group type: EXPERIMENTAL
Intervention: Motor Exercise (ME)
Number of subjects: 71
Study 32916181 — intervention group
Group type: EXPERIMENTAL
Intervention: Cardiovascular Exercise (CE)
Number of subjects: 71
Study 32916181 — intervention group
Group type: COMPARATOR
Intervention: Control Group (CON)
Number of subjects: 71
Study 35770578 — intervention group
Group type: EXPERIMENTAL
Intervention: Electroacupuncture (EA) at 2-Hz near the left cervical ganglia
Number of subjects: 24
Study 33503114 — intervention group
Group type: EXPERIMENTAL
Intervention: ProCore 20G FNB needle
Number of subjects: 20
Study 33503114 — intervention group
Group type: COMPARATOR
Intervention: 22G FNA needle
Number of subjects: 20
Study 32825517 — intervention group
Group type: EXPERIMENTAL
Intervention: NOURISH intervention for mothers (2 × 12 week modules starting at 4 and 14 months)
Number of subjects: 70
Study 35841016 — intervention group
Group type: EXPERIMENTAL
Intervention: 3% hydrogen peroxide solution
Number of subjects: 16
Study 35841016 — intervention group
Group type: COMPARATOR
Intervention: Water-moistened toothbrush
Number of subjects: 16
Study 35841016 — intervention group
Group type: COMPARATOR
Intervention: Comparison between intervention and control groups
Number of subjects: 16
Study 34488794 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical Activity (PA) intervention combining family-based PA counselling and after-school exercise clubs
Number of subjects: 506
Study 34488794 — intervention group
Group type: COMPARATOR
Intervention: No intervention (control group)
Number of subjects: 506
Study 34488794 — intervention group
Group type: EXPERIMENTAL
Intervention: Cost-effectiveness analysis
Number of subjects: 506
Study 34488794 — intervention group
Group type: EXPERIMENTAL
Intervention: Sensitivity analyses
Number of subjects: 506
Study 32222042 — intervention group
Group type: EXPERIMENTAL
Intervention: TRAIN (unilateral maximal voluntary contractions of the wrist extensors)
Number of subjects: 27
Study 32222042 — intervention group
Group type: EXPERIMENTAL
Intervention: TRAIN + STIM (MVCs of wrist extensors with simultaneous SR stimulation)
Number of subjects: 27
Study 32222042 — intervention group
Group type: EXPERIMENTAL
Intervention: TRAIN + STIM
Number of subjects: 27
Study 32796413 — intervention group
Group type: EXPERIMENTAL
Intervention: Phototherapy (630 nm, 4.6 J/cm2, 6 J per point, 16 points, LED session)
Number of subjects: 16
Study 32796413 — intervention group
Group type: EXPERIMENTAL
Intervention: Phototherapy (LED session)
Number of subjects: 16
Study 32796413 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PLA session)
Number of subjects: 16
Study 32109005 — intervention group
Group type: EXPERIMENTAL
Intervention: New amino acid-based infant formula (Blemil Plus Elemental)
Number of subjects: 30
Study 32109005 — intervention group
Group type: COMPARATOR
Intervention: Control formula (Neocate)
Number of subjects: 30
Study 36368248 — intervention group
Group type: EXPERIMENTAL
Intervention: Wormwood vaginal gel
Number of subjects: 76
Study 36368248 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 76
Study 32640318 — intervention group
Group type: EXPERIMENTAL
Intervention: Prophylactic cerebrospinal fluid drainage (CSFD) used in 78 patients (73.6%)
Number of subjects: 106
Study 32640318 — intervention group
Group type: COMPARATOR
Intervention: No cerebrospinal fluid drainage (CSFD) used in 28 patients (26.4%)
Number of subjects: 106
Study 32640318 — intervention group
Group type: EXPERIMENTAL
Intervention: Cerebrospinal fluid drainage (CSFD) complications
Number of subjects: 106
Study 32330415 — intervention group
Group type: EXPERIMENTAL
Intervention: Closed-loop demultiplexing brain-computer interface (BCI)
Number of subjects: 1
Study 35366528 — intervention group
Group type: EXPERIMENTAL
Intervention: tACS-30 (30 min/2 mA daily sessions for 3 days)
Number of subjects: 0
Study 35366528 — intervention group
Group type: EXPERIMENTAL
Intervention: tACS-60 (60 min/2 mA weekday sessions)
Number of subjects: 0
Study 35366528 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 33496330 — intervention group
Group type: EXPERIMENTAL
Intervention: Child Development Agents (CDA)
Number of subjects: 826
Study 33496330 — intervention group
Group type: EXPERIMENTAL
Intervention: Community Health Workers (CHW)
Number of subjects: 826
Study 33496330 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 826
Study 32941332 — intervention group
Group type: EXPERIMENTAL
Intervention: Scleral lenses (SLs)
Number of subjects: 26
Study 34247247 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinical-radiomics nomogram model
Number of subjects: 638
Study 34247247 — intervention group
Group type: EXPERIMENTAL
Intervention: Rad-score from radiomics features
Number of subjects: 638
Study 34247247 — intervention group
Group type: EXPERIMENTAL
Intervention: Calibration curves and Decision Curve Analysis (DCA)
Number of subjects: 638
Study 32461568 — intervention group
Group type: EXPERIMENTAL
Intervention: Arclight ophthalmoscope
Number of subjects: 40
Study 32461568 — intervention group
Group type: COMPARATOR
Intervention: Traditional ophthalmoscope (TO)
Number of subjects: 40
Study 32141043 — intervention group
Group type: EXPERIMENTAL
Intervention: Endoscopic ultrasound-guided liver biopsy (EUS-LB)
Number of subjects: 90
Study 32141043 — intervention group
Group type: COMPARATOR
Intervention: Percutaneous liver biopsy (PC-LB)
Number of subjects: 90
Study 33962026 — intervention group
Group type: EXPERIMENTAL
Intervention: Home-based multimodal exercise program (AD-HOMEX), 16-week protocol, three 60-minute sessions per week supervised by a physical therapist
Number of subjects: 40
Study 33962026 — intervention group
Group type: EXPERIMENTAL
Intervention: Home-based multimodal exercise program (AD-HOMEX)
Number of subjects: 40
Study 33962026 — intervention group
Group type: COMPARATOR
Intervention: Usual care (Control Group)
Number of subjects: 40
Study 33225982 — intervention group
Group type: EXPERIMENTAL
Intervention: Automated, individualized education through a smartphone app (Yi tang yun qiao)
Number of subjects: 138
Study 33225982 — intervention group
Group type: COMPARATOR
Intervention: Routine care
Number of subjects: 138
Study 35338534 — intervention group
Group type: EXPERIMENTAL
Intervention: 1-week massed cognitive processing therapy (CPT) delivered virtually, twice per day for 5 days
Number of subjects: 24
Study 33385632 — intervention group
Group type: EXPERIMENTAL
Intervention: Brain training games over a 30‐day period
Number of subjects: 352
Study 33385632 — intervention group
Group type: COMPARATOR
Intervention: Waitlist control group
Number of subjects: 352
Study 32981029 — intervention group
Group type: EXPERIMENTAL
Intervention: Phenazopyridine
Number of subjects: 120
Study 32981029 — intervention group
Group type: EXPERIMENTAL
Intervention: Celecoxib
Number of subjects: 120
Study 32981029 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxybutynin
Number of subjects: 120
Study 32981029 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 120
Study 35193056 — intervention group
Group type: EXPERIMENTAL
Intervention: Providing vouchers redeemable in local optical shops
Number of subjects: 251
Study 35193056 — intervention group
Group type: EXPERIMENTAL
Intervention: Health education campaign
Number of subjects: 251
Study 35193056 — intervention group
Group type: EXPERIMENTAL
Intervention: Free delivery to schools with a health education campaign
Number of subjects: 251
Study 35193056 — intervention group
Group type: COMPARATOR
Intervention: Voucher redemption or prescription for eyeglasses to be purchased on the market
Number of subjects: 251
Study 33737196 — intervention group
Group type: EXPERIMENTAL
Intervention: Gentle physical activity program delivered by home care aides
Number of subjects: 300
Study 33737196 — intervention group
Group type: COMPARATOR
Intervention: Control group (not explicitly mentioned)
Number of subjects: 300
Study 33507461 — intervention group
Group type: EXPERIMENTAL
Intervention: Bandage contact lens (BCL)
Number of subjects: 120
Study 33507461 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 120
Study 32981874 — intervention group
Group type: EXPERIMENTAL
Intervention: SMARTLock hybrid MMF
Number of subjects: 32
Study 32981874 — intervention group
Group type: COMPARATOR
Intervention: IMF screws
Number of subjects: 32
Study 35067356 — intervention group
Group type: EXPERIMENTAL
Intervention: Active dTMS
Number of subjects: 51
Study 35067356 — intervention group
Group type: COMPARATOR
Intervention: Sham control
Number of subjects: 51
Study 33556898 — intervention group
Group type: EXPERIMENTAL
Intervention: Nivolumab plus Ipilimumab (NIVO+IPI)
Number of subjects: 0
Study 33556898 — intervention group
Group type: COMPARATOR
Intervention: Dabrafenib plus Trametinib (DAB+TRAM)
Number of subjects: 0
Study 33556898 — intervention group
Group type: COMPARATOR
Intervention: Vemurafenib plus Cobimetinib (VEM+COBI)
Number of subjects: 0
Study 35365121 — intervention group
Group type: EXPERIMENTAL
Intervention: cM1 low frequency rTMS (n = 20)
Number of subjects: 60
Study 35365121 — intervention group
Group type: EXPERIMENTAL
Intervention: cPMd high frequency rTMS (n = 20)
Number of subjects: 60
Study 35365121 — intervention group
Group type: COMPARATOR
Intervention: Sham stimulation group (n = 20)
Number of subjects: 60
Study 33743679 — intervention group
Group type: EXPERIMENTAL
Intervention: Out-of-pocket payments (OOPs) by MS patients
Number of subjects: 300
Study 33743679 — intervention group
Group type: EXPERIMENTAL
Intervention: Occupational status, supplemental health insurance, residency in Tabriz
Number of subjects: 300
Study 32616227 — intervention group
Group type: EXPERIMENTAL
Intervention: Fractured keel (FK) hens
Number of subjects: 90
Study 32616227 — intervention group
Group type: COMPARATOR
Intervention: Normal keel (NK) hens
Number of subjects: 90
Study 36274566 — intervention group
Group type: EXPERIMENTAL
Intervention: Internet-based single-session intervention targeting parent accommodation
Number of subjects: 295
Study 34761749 — intervention group
Group type: EXPERIMENTAL
Intervention: Naltrexone
Number of subjects: 0
Study 34761749 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 34761749 — intervention group
Group type: EXPERIMENTAL
Intervention: Amisulpride
Number of subjects: 0
Study 35970918 — intervention group
Group type: EXPERIMENTAL
Intervention: 5.45% sodium chloride solution (group B)
Number of subjects: 657
Study 35970918 — intervention group
Group type: EXPERIMENTAL
Intervention: 10% sodium chloride solution (group C)
Number of subjects: 657
Study 35970918 — intervention group
Group type: COMPARATOR
Intervention: 0.9% sodium chloride solution (group A)
Number of subjects: 657
Study 32988366 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound group (n = 40)
Number of subjects: 80
Study 32988366 — intervention group
Group type: COMPARATOR
Intervention: Landmark group (n = 40)
Number of subjects: 80
Study 35713110 — intervention group
Group type: EXPERIMENTAL
Intervention: 10-week internet-based cognitive-behavioral therapy (iCBT), n = 26
Number of subjects: 52
Study 35713110 — intervention group
Group type: COMPARATOR
Intervention: Monitored attention control (MAC), n = 26
Number of subjects: 52
Study 34174187 — intervention group
Group type: EXPERIMENTAL
Intervention: Seasonal influenza vaccination
Number of subjects: 0
Study 34174187 — intervention group
Group type: EXPERIMENTAL
Intervention: AS03-adjuvanted H5N1 pandemic influenza vaccine
Number of subjects: 0
Study 33934320 — intervention group
Group type: EXPERIMENTAL
Intervention: CD for arrest of descent (n = 136)
Number of subjects: 525
Study 33934320 — intervention group
Group type: EXPERIMENTAL
Intervention: CD for arrest of dilation (n = 389)
Number of subjects: 525
Study 33934320 — intervention group
Group type: COMPARATOR
Intervention: Pre-2014 CD
Number of subjects: 525
Study 33934320 — intervention group
Group type: COMPARATOR
Intervention: Post-2014 CD
Number of subjects: 525
Study 33185716 — intervention group
Group type: EXPERIMENTAL
Intervention: Wearable UV sensor with structured goal setting
Number of subjects: 60
Study 33185716 — intervention group
Group type: COMPARATOR
Intervention: Wearable UV sensor with unstructured goal setting
Number of subjects: 60
Study 32444091 — intervention group
Group type: EXPERIMENTAL
Intervention: Ramipril
Number of subjects: 0
Study 32444091 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 35385778 — intervention group
Group type: EXPERIMENTAL
Intervention: Blastocyst culture supernatant transfer (Group A)
Number of subjects: 288
Study 35385778 — intervention group
Group type: COMPARATOR
Intervention: Embryo culture transfer (Group B)
Number of subjects: 288
Study 35385778 — intervention group
Group type: EXPERIMENTAL
Intervention: Blastocyst culture supernatant transfer (Group A) in patients aged ≥35 years
Number of subjects: 288
Study 35385778 — intervention group
Group type: COMPARATOR
Intervention: Embryo culture transfer (Group B) in patients aged ≥35 years
Number of subjects: 288
Study 33572988 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediately loaded prosthesis (one week)
Number of subjects: 21
Study 33572988 — intervention group
Group type: COMPARATOR
Intervention: Early-loaded prosthesis (four weeks)
Number of subjects: 21
Study 32164507 — intervention group
Group type: EXPERIMENTAL
Intervention: 177Lu-PSMA-radioligand therapy
Number of subjects: 0
Study 36161146 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 mg escitalopram
Number of subjects: 60
Study 36161146 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study 33939253 — intervention group
Group type: COMPARATOR
Intervention: Organ-based tube current modulation (OBTCM)
Number of subjects: 34
Study 33939253 — intervention group
Group type: COMPARATOR
Intervention: Automatic tube current modulation (ATCM)
Number of subjects: 34
Study 36368169 — intervention group
Group type: EXPERIMENTAL
Intervention: Telerehabilitation (TR) group received real-time motor-cognitive dual-task exercise treatment via video conferencing for 6 weeks
Number of subjects: 20
Study 36368169 — intervention group
Group type: COMPARATOR
Intervention: Control group received no intervention for 6 weeks
Number of subjects: 20
Study 35134323 — intervention group
Group type: EXPERIMENTAL
Intervention: Guselkumab 200 mg
Number of subjects: 309
Study 35134323 — intervention group
Group type: EXPERIMENTAL
Intervention: Guselkumab 600 mg
Number of subjects: 309
Study 35134323 — intervention group
Group type: EXPERIMENTAL
Intervention: Guselkumab 1200 mg
Number of subjects: 309
Study 35134323 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 309
Study 35134323 — intervention group
Group type: EXPERIMENTAL
Intervention: Ustekinumab
Number of subjects: 309
Study 34919983 — intervention group
Group type: EXPERIMENTAL
Intervention: Intranasal oxytocin (24 IU)
Number of subjects: 65
Study 34919983 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 65
Study 34168032 — intervention group
Group type: EXPERIMENTAL
Intervention: Anaerobic Cultivated Human Intestinal Microbiome (ACHIM)
Number of subjects: 70
Study 34168032 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 70
Study 34168032 — intervention group
Group type: EXPERIMENTAL
Intervention: ACHIM
Number of subjects: 70
Study 32221178 — intervention group
Group type: EXPERIMENTAL
Intervention: Antidepressive medications plus cognitive behavioral therapy
Number of subjects: 12
Study 32221178 — intervention group
Group type: EXPERIMENTAL
Intervention: Antidepressive medications plus dynamic psychotherapy
Number of subjects: 12
Study 32221178 — intervention group
Group type: EXPERIMENTAL
Intervention: Antidepressive medications plus psychotherapy (both types)
Number of subjects: 12
Study 34190962 — intervention group
Group type: EXPERIMENTAL
Intervention: Zuranolone, 30 mg, administered orally each evening for 2 weeks
Number of subjects: 153
Study 34190962 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 153
Study 34190962 — intervention group
Group type: EXPERIMENTAL
Intervention: Zuranolone, 30 mg
Number of subjects: 153
Study 33251929 — intervention group
Group type: EXPERIMENTAL
Intervention: Toothbrushing to the best of their abilities
Number of subjects: 174
Study 33251929 — intervention group
Group type: EXPERIMENTAL
Intervention: Time brushed by circular movements
Number of subjects: 174
Study 33251929 — intervention group
Group type: EXPERIMENTAL
Intervention: Number of sextants brushed for at least 7.5 s
Number of subjects: 174
Study 33251929 — intervention group
Group type: EXPERIMENTAL
Intervention: Circular movements
Number of subjects: 174
Study 33251929 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioral aspects related to inner surfaces
Number of subjects: 174
Study 33588112 — intervention group
Group type: EXPERIMENTAL
Intervention: Lymph Node Collection Kit
Number of subjects: 3734
Study 33588112 — intervention group
Group type: EXPERIMENTAL
Intervention: Heightened Awareness (HA)
Number of subjects: 3734
Study 33588112 — intervention group
Group type: COMPARATOR
Intervention: Preintervention (Baseline)
Number of subjects: 3734
Study 32585169 — intervention group
Group type: EXPERIMENTAL
Intervention: High-Intensity Interval Training (HIIT)
Number of subjects: 60
Study 32585169 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate-Intensity Continuous Training (MICT)
Number of subjects: 60
Study 32585169 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 60
Study 34000608 — intervention group
Group type: EXPERIMENTAL
Intervention: Pelvic belt during trunk stability exercises
Number of subjects: 24
Study 32915796 — intervention group
Group type: EXPERIMENTAL
Intervention: Vibration (Vib) during maximal graded cycling exercise
Number of subjects: 12
Study 32915796 — intervention group
Group type: COMPARATOR
Intervention: No Vibration (noVib) during maximal graded cycling exercise
Number of subjects: 12
Study 36424687 — intervention group
Group type: EXPERIMENTAL
Intervention: Melatonin 5 mg
Number of subjects: 84
Study 36424687 — intervention group
Group type: COMPARATOR
Intervention: Placebo (identical glucose tablets)
Number of subjects: 84
Study 32789528 — intervention group
Group type: COMPARATOR
Intervention: Montmorency tart cherry juice (MTCJ) supplementation for 7 days
Number of subjects: 12
Study 34690065 — intervention group
Group type: EXPERIMENTAL
Intervention: Spironolactone 25 mg daily for 3 months
Number of subjects: 102
Study 34690065 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 102
Study 36347450 — intervention group
Group type: EXPERIMENTAL
Intervention: Green tea (GT) supplementation (738 mg)
Number of subjects: 15
Study 36347450 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study 33872056 — intervention group
Group type: EXPERIMENTAL
Intervention: ACLR+LET
Number of subjects: 18
Study 33872056 — intervention group
Group type: COMPARATOR
Intervention: iACLR
Number of subjects: 18
Study 35646354 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary counseling
Number of subjects: 60
Study 35646354 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical activity counseling
Number of subjects: 60
Study 35646354 — intervention group
Group type: EXPERIMENTAL
Intervention: Diet and physical activity counseling
Number of subjects: 60
Study 35646354 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 60
Study 36107598 — intervention group
Group type: EXPERIMENTAL
Intervention: Superficial serratus plane block
Number of subjects: 60
Study 33025645 — intervention group
Group type: EXPERIMENTAL
Intervention: 6-mm implants
Number of subjects: 95
Study 33025645 — intervention group
Group type: COMPARATOR
Intervention: 11-mm implants
Number of subjects: 95
Study 32780138 — intervention group
Group type: EXPERIMENTAL
Intervention: Liberal transfusion thresholds (n=492)
Number of subjects: 1013